NTRA

Natera, Inc.

SEC CIK 1604821
$212.07 +3.1% · 90 days
90-day buys
$0
0 open-market
90-day sells
$37.81M
80 open-market
Net insider flow
−$37.81M
Net selling
Filings shown
91
Most recent

At a glance

Over the last 90 days, insiders at NTRA have sold a net $37.81M of stock (0 open-market buys vs 80 sells).

Largest recent trade: Botha Roelof sold $5.78M of NTRA, trimming their stake 2%.

Most active filer: Sheena Jonathan, with 18 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for NTRA, newest first
View on SEC EDGAR ↗
NTRA
Sell Marcus Gail Boxer · Director · Open-market sale · filed 3d ago ΔOwn −18%

Marcus Gail Boxer sold $651.6K of NTRA, trimming their stake 18%.

−$651.6K
3,016 sh @ $216
NTRA
Sell Marcus Gail Boxer · Director · Open-market sale · filed 3d ago ΔOwn −33%

Marcus Gail Boxer sold $1.02M of NTRA, trimming their stake 33%.

−$1.02M
4,694 sh @ $217
NTRA
Sell Marcus Gail Boxer · Director · Open-market sale · filed 3d ago ΔOwn −34%

Marcus Gail Boxer sold $692.3K of NTRA, trimming their stake 34%.

−$692.3K
3,174 sh @ $218
NTRA
Sell Marcus Gail Boxer · Director · Open-market sale · filed 3d ago ΔOwn −1.8%

Marcus Gail Boxer sold $25.4K of NTRA, trimming their stake 2%.

−$25.4K
116 sh @ $219
NTRA
Sell Chapman Steven Leonard · Director, CEO AND PRESIDENT · Open-market sale · filed 1w ago ΔOwn −0.6%

Chapman Steven Leonard sold $176.7K of NTRA, trimming their stake 1%.

−$176.7K
832 sh @ $212
NTRA
Sell Chapman Steven Leonard · Director, CEO AND PRESIDENT · Open-market sale · filed 1w ago ΔOwn −1.7%

Chapman Steven Leonard sold $534.3K of NTRA, trimming their stake 2%.

−$534.3K
2,503 sh @ $213
NTRA
Sell Chapman Steven Leonard · Director, CEO AND PRESIDENT · Open-market sale · filed 1w ago ΔOwn −0.9%

Chapman Steven Leonard sold $279.3K of NTRA, trimming their stake 1%.

−$279.3K
1,300 sh @ $215
NTRA
Sell Chapman Steven Leonard · Director, CEO AND PRESIDENT · Open-market sale · filed 1w ago ΔOwn −3.8%

Chapman Steven Leonard sold $1.19M of NTRA, trimming their stake 4%.

−$1.19M
5,499 sh @ $216
NTRA
Sell Chapman Steven Leonard · Director, CEO AND PRESIDENT · Open-market sale · filed 1w ago ΔOwn −1.7%

Chapman Steven Leonard sold $510.3K of NTRA, trimming their stake 2%.

−$510.3K
2,351 sh @ $217
NTRA
Sell Chapman Steven Leonard · Director, CEO AND PRESIDENT · Open-market sale · filed 1w ago ΔOwn −1.3%

Chapman Steven Leonard sold $380.3K of NTRA, trimming their stake 1%.

−$380.3K
1,742 sh @ $218
NTRA
Sell Chapman Steven Leonard · Director, CEO AND PRESIDENT · Open-market sale · filed 1w ago ΔOwn −2.0%

Chapman Steven Leonard sold $604.2K of NTRA, trimming their stake 2%.

−$604.2K
2,758 sh @ $219
NTRA
Sell Chapman Steven Leonard · Director, CEO AND PRESIDENT · Open-market sale · filed 1w ago ΔOwn −1.8%

Chapman Steven Leonard sold $528.5K of NTRA, trimming their stake 2%.

−$528.5K
2,400 sh @ $220
NTRA
Sell Chapman Steven Leonard · Director, CEO AND PRESIDENT · Open-market sale · filed 1w ago ΔOwn −1.5%

Chapman Steven Leonard sold $445.8K of NTRA, trimming their stake 2%.

−$445.8K
2,006 sh @ $222
NTRA
Sell Chapman Steven Leonard · Director, CEO AND PRESIDENT · Open-market sale · filed 1w ago ΔOwn −5.1%

Chapman Steven Leonard sold $1.45M of NTRA, trimming their stake 5%.

−$1.45M
6,500 sh @ $223
NTRA
Sell Chapman Steven Leonard · Director, CEO AND PRESIDENT · Open-market sale · filed 1w ago ΔOwn −1.2%

Chapman Steven Leonard sold $323.1K of NTRA, trimming their stake 1%.

−$323.1K
1,443 sh @ $224
NTRA
Sell Chapman Steven Leonard · Director, CEO AND PRESIDENT · Open-market sale · filed 1w ago ΔOwn −1.4%

Chapman Steven Leonard sold $366.7K of NTRA, trimming their stake 1%.

−$366.7K
1,630 sh @ $225
NTRA
Sell Chapman Steven Leonard · Director, CEO AND PRESIDENT · Open-market sale · filed 1w ago ΔOwn −5.7%

Chapman Steven Leonard sold $1.53M of NTRA, trimming their stake 6%.

−$1.53M
6,751 sh @ $226
NTRA
Sell Chapman Steven Leonard · Director, CEO AND PRESIDENT · Open-market sale · filed 1w ago ΔOwn −3.0%

Chapman Steven Leonard sold $773.7K of NTRA, trimming their stake 3%.

−$773.7K
3,409 sh @ $227
NTRA
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed 1w ago ΔOwn −1.3%

Moshkevich Solomon sold $392K of NTRA, trimming their stake 1%.

−$392K
1,802 sh @ $218
NTRA
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed 1w ago ΔOwn −0.3%

Moshkevich Solomon sold $90.4K of NTRA.

−$90.4K
413 sh @ $219
NTRA
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed 1w ago ΔOwn −0.2%

Moshkevich Solomon sold $46.7K of NTRA.

−$46.7K
213 sh @ $219
NTRA
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed 1w ago ΔOwn −0.4%

Moshkevich Solomon sold $126.2K of NTRA.

−$126.2K
572 sh @ $221
NTRA
Sell BOTHA ROELOF · Director · Open-market sale · filed 1w ago ΔOwn −2.3%

Botha Roelof sold $5.78M of NTRA, trimming their stake 2%.

−$5.78M
26,411 sh @ $219
NTRA
Sell BOTHA ROELOF · Director · Open-market sale · filed 1w ago ΔOwn −0.9%

Botha Roelof sold $2.22M of NTRA, trimming their stake 1%.

−$2.22M
10,100 sh @ $220
NTRA
Sell BOTHA ROELOF · Director · Open-market sale · filed 1w ago ΔOwn −1.9%

Botha Roelof sold $4.71M of NTRA, trimming their stake 2%.

−$4.71M
21,304 sh @ $221
NTRA
Sell BOTHA ROELOF · Director · Open-market sale · filed 1w ago ΔOwn −1.4%

Botha Roelof sold $3.3M of NTRA, trimming their stake 1%.

−$3.3M
14,885 sh @ $222
NTRA
Sell BOTHA ROELOF · Director · Open-market sale · filed 1w ago ΔOwn −0.3%

Botha Roelof sold $635K of NTRA.

−$635K
2,850 sh @ $223
NTRA
Sell BOTHA ROELOF · Director · Open-market sale · filed 1w ago ΔOwn −0.2%

Botha Roelof sold $548.4K of NTRA.

−$548.4K
2,450 sh @ $224
NTRA
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed 2w ago ΔOwn −1.2%

Moshkevich Solomon sold $335.1K of NTRA, trimming their stake 1%.

−$335.1K
1,652 sh @ $203
NTRA
Sell Fesko John · PRESIDENT, CHIEF BUS. OFFICER · Open-market sale · filed 2w ago ΔOwn −0.8%

Fesko John sold $291.7K of NTRA, trimming their stake 1%.

−$291.7K
1,438 sh @ $203
NTRA
Sell Sheena Jonathan · Director · Open-market sale · filed 4w ago ΔOwn −0.4%

Sheena Jonathan sold $17K of NTRA.

−$17K
85 sh @ $200
NTRA
Sell Sheena Jonathan · Director · Open-market sale · filed 4w ago ΔOwn −1.7%

Sheena Jonathan sold $69.4K of NTRA, trimming their stake 2%.

−$69.4K
345 sh @ $201
NTRA
Sell Sheena Jonathan · Director · Open-market sale · filed 4w ago ΔOwn −1.5%

Sheena Jonathan sold $58.7K of NTRA, trimming their stake 1%.

−$58.7K
290 sh @ $203
NTRA
Sell Sheena Jonathan · Director · Open-market sale · filed 4w ago ΔOwn −0.2%

Sheena Jonathan sold $6.1K of NTRA.

−$6.1K
30 sh @ $203
NTRA
Sell Sheena Jonathan · Director · Open-market sale · filed 4w ago ΔOwn −0.5%

Sheena Jonathan sold $19.1K of NTRA.

−$19.1K
96 sh @ $199
NTRA
Sell Sheena Jonathan · Director · Open-market sale · filed 4w ago ΔOwn −1.8%

Sheena Jonathan sold $72.4K of NTRA, trimming their stake 2%.

−$72.4K
360 sh @ $201
NTRA
Sell Sheena Jonathan · Director · Open-market sale · filed 4w ago ΔOwn −1.4%

Sheena Jonathan sold $57.8K of NTRA, trimming their stake 1%.

−$57.8K
285 sh @ $203
NTRA
Sell Sheena Jonathan · Director · Open-market sale · filed 4w ago

Sheena Jonathan sold $1.8K of NTRA.

−$1.8K
9 sh @ $203
NTRA
Sell Sheena Jonathan · Director · Open-market sale · filed 4w ago ΔOwn −0.1%

Sheena Jonathan sold $41.1K of NTRA.

−$41.1K
200 sh @ $205
NTRA
Sell Sheena Jonathan · Director · Open-market sale · filed 4w ago ΔOwn −0.4%

Sheena Jonathan sold $186.5K of NTRA.

−$186.5K
900 sh @ $207
NTRA
Sell Sheena Jonathan · Director · Open-market sale · filed 4w ago ΔOwn −0.3%

Sheena Jonathan sold $145.7K of NTRA.

−$145.7K
700 sh @ $208
NTRA
Sell Sheena Jonathan · Director · Open-market sale · filed 4w ago ΔOwn −0.1%

Sheena Jonathan sold $41.9K of NTRA.

−$41.9K
200 sh @ $210
NTRA
Sell Sheena Jonathan · Director · Open-market sale · filed 4w ago ΔOwn −0.5%

Sheena Jonathan sold $241.9K of NTRA.

−$241.9K
1,150 sh @ $210
NTRA
Sell Rabinowitz Matthew · Director, EXECUTIVE CHAIRMAN · Open-market sale · filed May 6, 2026 ΔOwn −0.1%

Rabinowitz Matthew sold $596.9K of NTRA.

−$596.9K
2,887 sh @ $207
NTRA
Sell Rabinowitz Matthew · Director, EXECUTIVE CHAIRMAN · Open-market sale · filed May 6, 2026 ΔOwn −0.1%

Rabinowitz Matthew sold $351K of NTRA.

−$351K
1,454 sh @ $241
NTRA
Sell Rabinowitz Matthew · Director, EXECUTIVE CHAIRMAN · Open-market sale · filed May 6, 2026 ΔOwn −0.1%

Rabinowitz Matthew sold $350.9K of NTRA.

−$350.9K
1,697 sh @ $207
NTRA
Sell Rabinowitz Matthew · Director, EXECUTIVE CHAIRMAN · Open-market sale · filed May 6, 2026

Rabinowitz Matthew sold $194.5K of NTRA.

−$194.5K
948 sh @ $205
NTRA
Sell Rabinowitz Matthew · Director, EXECUTIVE CHAIRMAN · Open-market sale · filed May 6, 2026

Rabinowitz Matthew sold $148.8K of NTRA.

−$148.8K
722 sh @ $206
NTRA
Sell Brophy Michael Burkes · CHIEF FINANCIAL OFFICER · Open-market sale · filed May 5, 2026 ΔOwn −0.8%

Brophy Michael Burkes sold $101.5K of NTRA, trimming their stake 1%.

−$101.5K
482 sh @ $210
NTRA
Sell Brophy Michael Burkes · CHIEF FINANCIAL OFFICER · Open-market sale · filed May 5, 2026 ΔOwn −0.5%

Brophy Michael Burkes sold $64.5K of NTRA, trimming their stake 1%.

−$64.5K
313 sh @ $206
NTRA
Sell Sheena Jonathan · Director · Open-market sale · filed May 5, 2026

Sheena Jonathan sold $22.1K of NTRA.

−$22.1K
107 sh @ $206
NTRA
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed May 5, 2026 ΔOwn −0.3%

Moshkevich Solomon sold $83.5K of NTRA.

−$83.5K
405 sh @ $206
NTRA
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed May 5, 2026 ΔOwn −0.4%

Moshkevich Solomon sold $112.5K of NTRA.

−$112.5K
560 sh @ $201
NTRA
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed May 5, 2026 ΔOwn −0.4%

Moshkevich Solomon sold $104.8K of NTRA.

−$104.8K
520 sh @ $202
NTRA
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed May 5, 2026 ΔOwn −0.4%

Moshkevich Solomon sold $102.7K of NTRA.

−$102.7K
505 sh @ $203
NTRA
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed May 5, 2026 ΔOwn −0.6%

Moshkevich Solomon sold $176.9K of NTRA, trimming their stake 1%.

−$176.9K
865 sh @ $204
NTRA
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed May 5, 2026 ΔOwn −0.3%

Moshkevich Solomon sold $82.1K of NTRA.

−$82.1K
400 sh @ $205
NTRA
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed May 5, 2026 ΔOwn −0.1%

Moshkevich Solomon sold $31K of NTRA.

−$31K
150 sh @ $207
NTRA
Sell Fesko John · PRESIDENT, CHIEF BUS. OFFICER · Open-market sale · filed May 5, 2026 ΔOwn −0.2%

Fesko John sold $60K of NTRA.

−$60K
291 sh @ $206
NTRA
Sell Chapman Steven Leonard · Director, CEO AND PRESIDENT · Open-market sale · filed May 5, 2026 ΔOwn −0.6%

Chapman Steven Leonard sold $186K of NTRA, trimming their stake 1%.

−$186K
902 sh @ $206
NTRA
Sell RABINOWITZ DANIEL · SEC. AND CHIEF LEGAL OFFICER · Open-market sale · filed May 5, 2026 ΔOwn −0.1%

Rabinowitz Daniel sold $68K of NTRA.

−$68K
330 sh @ $206
NTRA
Sell Brophy Michael Burkes · CHIEF FINANCIAL OFFICER · Open-market sale · filed Apr 29, 2026 ΔOwn −0.5%

Brophy Michael Burkes sold $57K of NTRA.

−$57K
300 sh @ $190
NTRA
Sell Brophy Michael Burkes · CHIEF FINANCIAL OFFICER · Open-market sale · filed Apr 29, 2026 ΔOwn −0.8%

Brophy Michael Burkes sold $96.1K of NTRA, trimming their stake 1%.

−$96.1K
500 sh @ $192
NTRA
Sell Brophy Michael Burkes · CHIEF FINANCIAL OFFICER · Open-market sale · filed Apr 29, 2026 ΔOwn −1.7%

Brophy Michael Burkes sold $193.8K of NTRA, trimming their stake 2%.

−$193.8K
1,000 sh @ $194
NTRA
Sell Brophy Michael Burkes · CHIEF FINANCIAL OFFICER · Open-market sale · filed Apr 29, 2026 ΔOwn −1.8%

Brophy Michael Burkes sold $208.5K of NTRA, trimming their stake 2%.

−$208.5K
1,070 sh @ $195
NTRA
Sell Brophy Michael Burkes · CHIEF FINANCIAL OFFICER · Open-market sale · filed Apr 29, 2026 ΔOwn −0.3%

Brophy Michael Burkes sold $39.5K of NTRA.

−$39.5K
200 sh @ $197
NTRA
Sell Sheena Jonathan · Director · Open-market sale · filed Apr 29, 2026 ΔOwn −0.9%

Sheena Jonathan sold $444.6K of NTRA, trimming their stake 1%.

−$444.6K
2,266 sh @ $196
NTRA
Sell Sheena Jonathan · Director · Open-market sale · filed Apr 29, 2026 ΔOwn −0.3%

Sheena Jonathan sold $158.6K of NTRA.

−$158.6K
805 sh @ $197
NTRA
Sell Brophy Michael Burkes · CHIEF FINANCIAL OFFICER · Open-market sale · filed Apr 29, 2026 ΔOwn −1.2%

Brophy Michael Burkes sold $157.1K of NTRA, trimming their stake 1%.

−$157.1K
771 sh @ $204
NTRA
Sell Brophy Michael Burkes · CHIEF FINANCIAL OFFICER · Open-market sale · filed Apr 29, 2026 ΔOwn −2.0%

Brophy Michael Burkes sold $249.8K of NTRA, trimming their stake 2%.

−$249.8K
1,222 sh @ $204
NTRA
Sell Chapman Steven Leonard · Director, CEO AND PRESIDENT · Open-market sale · filed Apr 29, 2026 ΔOwn −1.5%

Chapman Steven Leonard sold $462.9K of NTRA, trimming their stake 1%.

−$462.9K
2,272 sh @ $204
NTRA
Sell Chapman Steven Leonard · Director, CEO AND PRESIDENT · Open-market sale · filed Apr 29, 2026 ΔOwn −2.3%

Chapman Steven Leonard sold $728.9K of NTRA, trimming their stake 2%.

−$728.9K
3,566 sh @ $204
NTRA
Sell Fesko John · PRESIDENT, CHIEF BUS. OFFICER · Open-market sale · filed Apr 29, 2026 ΔOwn −0.4%

Fesko John sold $157.1K of NTRA.

−$157.1K
771 sh @ $204
NTRA
Sell Fesko John · PRESIDENT, CHIEF BUS. OFFICER · Open-market sale · filed Apr 29, 2026 ΔOwn −0.5%

Fesko John sold $187.4K of NTRA.

−$187.4K
917 sh @ $204
NTRA
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Apr 29, 2026 ΔOwn −0.7%

Moshkevich Solomon sold $203.1K of NTRA, trimming their stake 1%.

−$203.1K
997 sh @ $204
NTRA
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Apr 29, 2026 ΔOwn −0.8%

Moshkevich Solomon sold $242.2K of NTRA, trimming their stake 1%.

−$242.2K
1,185 sh @ $204
NTRA
Sell RABINOWITZ DANIEL · SEC. AND CHIEF LEGAL OFFICER · Open-market sale · filed Apr 29, 2026 ΔOwn −0.4%

Rabinowitz Daniel sold $177.9K of NTRA.

−$177.9K
873 sh @ $204
NTRA
Sell RABINOWITZ DANIEL · SEC. AND CHIEF LEGAL OFFICER · Open-market sale · filed Apr 29, 2026 ΔOwn −0.4%

Rabinowitz Daniel sold $201.9K of NTRA.

−$201.9K
988 sh @ $204
NTRA
Sell Sheena Jonathan · Director · Open-market sale · filed Apr 29, 2026 ΔOwn −0.1%

Sheena Jonathan sold $58.1K of NTRA.

−$58.1K
285 sh @ $204
NTRA
Sell Sheena Jonathan · Director · Open-market sale · filed Apr 29, 2026 ΔOwn −0.1%

Sheena Jonathan sold $38.4K of NTRA.

−$38.4K
188 sh @ $204

About NTRA insider activity

This page tracks every recent Form 4 filed for Natera, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is NTRA insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Natera, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.